Gene · 391
Papers1,903
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 1,903
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Simulation of the Internal Temperature Field and Flow Field in a Double-Layer Sintering Bed. | ACS Omega | 2022 | 36570293 | PubTator, text mining | PubMed |
IQ Motif Containing GTPase Activating Proteins (IQGAPs), A-Kinase Anchoring Proteins (AKAPs) and Kinase Suppressor of Ras Proteins (KSRs) in Scaffolding Oncogenic Pathways and Their Therapeutic Potential. | ACS Omega | 2022 | 36570181 | PubTator, text mining | PubMed |
| RAC1, a Potential Diagnostic and Prognostic Marker for Diffuse Large B Cell Lymphoma. | Cells | 2022 | 36552804 | PubTator, text mining | PubMed |
| Overexpression of SMS in the tumor microenvironment is associated with immunosuppression in hepatocellular carcinoma. | Front Immunol | 2022 | 36544774 | PubTator, text mining | PubMed |
| Novel targets in renal fibrosis based on bioinformatic analysis. | Front Genet | 2022 | 36523757 | PubTator, text mining | PubMed |
| Brain metastatic outgrowth and osimertinib resistance are potentiated by RhoA in EGFR-mutant lung cancer. | Nat Commun | 2022 | 36509758 | PubTator, text mining | PubMed |
| Joining Forces for Cancer Treatment: From "TCR versus CAR" to "TCR and CAR". | Int J Mol Sci | 2022 | 36498890 | PubTator, text mining | PubMed |
| Rnd3 Is a Crucial Mediator of the Invasive Phenotype of Glioblastoma Cells Downstream of Receptor Tyrosine Kinase Signalling. | Cells | 2022 | 36496976 | PubTator, text mining | PubMed |
| TGFβ1 induces myofibroblast transdifferentiation via increasing Smad-mediated RhoGDI-RhoGTPase signaling. | Gen Physiol Biophys | 2022 | 36454112 | PubTator, text mining | PubMed |
| Transcriptome profiling of colorectal tumors from patients with sepsis reveals an ethnic basis for viral infection risk and sepsis progression. | Sci Rep | 2022 | 36450776 | PubTator, text mining | PubMed |
| MiR-302d inhibits TGFB-induced EMT and promotes MET in primary human RPE cells. | PLoS One | 2022 | 36441751 | PubTator, text mining | PubMed |
| Interaction kinetics between p115-RhoGEF and Gα13 are determined by unique molecular interactions affecting agonist sensitivity. | Commun Biol | 2022 | 36434027 | PubTator, text mining | PubMed |
| Actin Up: An Overview of the Rac GEF Dock1/Dock180 and Its Role in Cytoskeleton Rearrangement. | Cells | 2022 | 36428994 | PubTator, text mining | PubMed |
| The integrated transcriptome bioinformatics analysis identifies key genes and cellular components for proliferative diabetic retinopathy. | PLoS One | 2022 | 36409751 | PubTator, text mining | PubMed |
| GNAQ mutations drive port wine birthmark-associated Sturge-Weber syndrome: A review of pathobiology, therapies, and current models. | Front Hum Neurosci | 2022 | 36405075 | PubTator, text mining | PubMed |
| Rho family GTPase signaling through type II p21-activated kinases. | Cell Mol Life Sci | 2022 | 36401658 | PubTator, text mining | PubMed |
| Biasing the conformation of ELMO2 reveals that myoblast fusion can be exploited to improve muscle regeneration. | Nat Commun | 2022 | 36400788 | PubTator, text mining | PubMed |
| GLP-1 RA Improves Diabetic Retinopathy by Protecting the Blood-Retinal Barrier through GLP-1R-ROCK-p-MLC Signaling Pathway. | J Diabetes Res | 2022 | 36387940 | PubTator, text mining | PubMed |
| Circ_0084043-miR-134-5p axis regulates PCDH9 to suppress melanoma. | Front Oncol | 2022 | 36387162 | PubTator, text mining | PubMed |
| Hemophagocytic lymphohistiocytosis as an etiology of bone marrow failure. | Front Oncol | 2022 | 36387094 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/391/papers?page=11